Rein Therapeutics, Inc. Payments of Stock Issuance Costs
Rein Therapeutics, Inc. (RNTX) reported Payments of Stock Issuance Costs of $893.00 thousand for the 9-month period ending 2025-09-30, per its 10-Q filed 2025-11-14.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsOfStockIssuanceCosts · last filed 2025-11-14
- Rein Therapeutics, Inc. payments of stock issuance costs for the quarter ending 2025-09-30 was $0.00.
- Rein Therapeutics, Inc. payments of stock issuance costs for the quarter ending 2025-06-30 was $0.00.
- Rein Therapeutics, Inc. payments of stock issuance costs for the quarter ending 2025-03-31 was $893.00K, a 0.00% change year-over-year.
- Rein Therapeutics, Inc. payments of stock issuance costs for the quarter ending 2024-12-31 was $0.00.
- Rein Therapeutics, Inc. payments of stock issuance costs for fiscal 2024 was $893.00K, a 0.00% change from fiscal 2023.
- Rein Therapeutics, Inc. payments of stock issuance costs for fiscal 2023 was $893.00K.
- Rein Therapeutics, Inc. payments of stock issuance costs for fiscal 2019 was $39.00K.
- Rein Therapeutics, Inc. payments of stock issuance costs for fiscal 2017 was $2.30M, a 1180.00% increase from fiscal 2016.
| Period end | Payments of Stock Issuance Costs 1 month | Payments of Stock Issuance Costs 3 month | Payments of Stock Issuance Costs 6 month | Payments of Stock Issuance Costs 9 month | Payments of Stock Issuance Costs 12 month |
|---|---|---|---|---|---|
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $0.00 derived: sum of 2 quarters · filed 2025-11-14 | $893.00K 10-Q · filed 2025-11-14 | $893.00K derived: sum of 4 quarters · filed 2025-11-14 | |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $893.00K 10-Q · filed 2025-08-14 | $893.00K derived: sum of 3 quarters · filed 2025-08-14 | $893.00K derived: sum of 4 quarters · filed 2025-08-14 | |
| 2025-03-31 | $893.00K 10-Q · filed 2025-05-15 | $893.00K derived: sum of 2 quarters · filed 2025-05-15 | $893.00K derived: sum of 3 quarters · filed 2025-05-15 | $893.00K derived: sum of 4 quarters · filed 2025-05-15 | |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-07 | $0.00 derived: sum of 2 quarters · filed 2025-04-07 | $0.00 derived: sum of 3 quarters · filed 2025-04-07 | $893.00K 10-K · filed 2025-04-07 | |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $0.00 derived: sum of 2 quarters · filed 2024-11-14 | $893.00K 10-Q · filed 2024-11-14 | ||
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $893.00K 10-Q · filed 2024-08-14 | |||
| 2024-03-31 | $893.00K 10-Q · filed 2024-05-15 | ||||
| 2023-12-31 | $893.00K 10-K · filed 2024-04-15 | ||||
| 2021-03-31 | $3.48M 10-Q · filed 2021-05-11 | ||||
| 2020-12-31 | $1.49M 10-Q · filed 2021-05-11 | ||||
| 2020-09-30 | $159.00K 10-Q · filed 2020-11-12 | $1.34M derived: sum of 2 quarters · filed 2020-11-12 | $1.37M derived: sum of 3 quarters · filed 2020-11-12 | ||
| 2020-06-30 | $1.19M 10-Q · filed 2020-11-12 | $1.21M derived: sum of 2 quarters · filed 2020-11-12 | |||
| 2020-03-31 | $28.00K 10-Q · filed 2020-08-05 | ||||
| 2019-12-31 | $39.00K 10-K · filed 2020-03-30 | ||||
| 2019-09-30 | $37.00K 10-Q · filed 2020-11-12 | ||||
| 2017-12-31 | $255.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-29 | $1.89M derived: sum of 2 quarters · filed 2019-03-29 | $2.30M 10-K · filed 2019-03-29 | ||
| 2017-09-30 | $1.63M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | $2.05M 10-Q · filed 2018-11-07 | |||
| 2017-06-30 | $419.00K 10-Q · filed 2018-08-07 | ||||
| 2017-02-28 | $32.00K 10-K · filed 2018-04-02 | ||||
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-04-02 | $0.00 derived: sum of 2 quarters · filed 2018-04-02 | $180.00K 10-K · filed 2018-04-02 | ||
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | $180.00K 10-Q · filed 2017-11-09 | |||
| 2016-06-30 | $180.00K 10-Q · filed 2017-08-10 | ||||
| 2015-12-31 | $1.32M 10-K · filed 2018-04-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |